The Global Shift in Cannabis Policy by data: Insights from the US and Germany
The US Perspective: Rescheduling Cannabis The proposal to reschedule cannabis from Schedule I to Schedule III in the United States marks a significant shift in federal drug policy. Historically, Schedule I drugs are classified as having a high potential for abuse and no accepted medical use, making them illegal to prescribe under federal law. Cannabis […]
The Global Shift in Cannabis Policy by data: Insights from the US and Germany Read More »
